(Q35029711)

English

Scleroderma and sclerotic skin conditions: unapproved treatments

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Scleroderma and sclerotic skin conditions: unapproved treatments (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Stefania Jabłońska

1

object named as

Stefania Jablonska

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Maria Blaszczyk

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Clinics in Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

634-637

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Questions regarding the design of the study of pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of scleroderma with PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PUVA-cream photochemotherapy for the treatment of localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose UVA1 radiation therapy for localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose UVA phototherapy for treatment of localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of severe scleroderma with long-term extracorporeal photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical calcipotriene for morphea/linear scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900283-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0738-081X(02)00283-3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35029711&oldid=1993724444"